Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Current Trial Report: A Multicenter Phase I/Ib Study of Capmatinib Plus Trametinib in Patients with Metastatic Non-Small Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations

Matthew S. Lara,Jonathan W. Riess,Jonathan W. Goldman, Fei Jiang,Trever G. Bivona,Collin M. Blakely

CLINICAL LUNG CANCER（2024）

Cited 0|Views4
Key words
MET exon skipping mutation,Non-small cell lung cancer,MAPK signaling,Capmatinib,Trametinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined